Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer [Phase 2]
Phase II clinical trial evaluating SHR-A1811 in patients with HER2-expressing or HER2-amplified biliary tract cancer; recruitment is ongoing…
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma [NA]
This NOT_YET_RECRUITING clinical trial is evaluating a three-drug combination of irinotecan liposome, capecitabine, and lenvatinib in biliar…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Nutritional Support for Patients Operated for Malignant Tumors in HPD Zone [NA]
Completed clinical trial evaluating nutritional support for patients operated for hepatobiliary neoplasms.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies [Phase 1]
This clinical trial update reports a Phase 1 study evaluating the combination of adebrelimab with apatinib, gemcitabine, and cisplatin in bi…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating HAIC plus Adebrelimab and Lenvatinib as conversion therapy for potentially resectable, locally advanced biliary tra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Phase II Study of Sitravatinib in Combination With Tislelizumab in Patients With Advanced Biliary Tract Cancer [Phase 2]
Phase II trial evaluating combination of sitravatinib and tislelizumab in patients with advanced biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer [Phase 2]
Phase 2 umbrella trial evaluating DDR-targeting agents in advanced biliary tract cancer; currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer [Phase 2]
Phase 2 trial evaluating Durvalumab (MEDI4736) and Tremelimumab with gemcitabine/cisplatin in chemotherapy-naïve biliary tract cancer (activ…
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC) [Phase 2]
Phase 2 trial of DKN-01 plus nivolumab in advanced biliary tract cancer has been terminated; results were posted on 2024-04-10.
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Durvalumab Combined With Surufatinib as Maintenance Therapy in Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating durvalumab with surufatinib as maintenance therapy in advanced biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy [Phase 1, Phase 2]
An exploratory Phase 1/2 trial evaluating a therapeutic effect prediction model for biliary tract cancer in the context of immunotherapy.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer. [Phase 2]
Phase 2 trial evaluating camrelizumab with apatinib and capecitabine in advanced biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966) [Phase 3]
A Phase 3 trial (MK-3475-966/KEYNOTE-966) evaluating pembrolizumab plus gemcitabine/cisplatin versus placebo plus gemcitabine/cisplatin as f…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update for RC48-ADC in HER2-overexpressed metastatic biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2023-12-07Clinical Trial Update: A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors [Phase 1, Phase 2]
Results from a Phase 1/2 study of INCB001158 in combination with chemotherapy for solid tumors, including biliary tract cancer and colorecta…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial update evaluating cadonilimab plus regorafenib and gemcitabine-cisplatin chemotherapy in advanced biliary tract cance…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus toripalimab for advanced biliary tract cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase [Phase 1, Phase 2]
Phase 1 dose-escalation and Phase 2 dose-expansion study of D07001-Softgel Capsules in gastrointestinal and biliary tract cancers completed …
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial investigating a combination of hepatic artery infusion chemotherapy (HAIC), surufatinib, and tislelizumab for unresec…
-
CLINICAL_TRIALS trial_result · 2023-11-15Clinical Trial Update: Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 trial evaluating durvalumab and lenvatinib with or without chemotherapy as first-line treatment for advanced biliary tract cancer …
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Pembrolizumab in Biliary Tract Cancer [Phase 2]
Phase 2 trial update of pembrolizumab in biliary tract cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations [Phase 2]
Phase 2 trial investigating olaparib for metastatic biliary tract cancer with aberrant DNA repair gene mutations.
-
CLINICAL_TRIALS trial_result · 2023-10-11Clinical Trial Update: Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy [Phase 2]
Phase 2 trial evaluating trastuzumab-pkrb with modified FOLFOX-6 in HER2-positive biliary tract cancer progressed after first-line therapy h…
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients [Phase 2]
Phase 2 trial investigating immune checkpoint inhibitors combined with radiation therapy in metastatic pancreatic cancer and metastatic bili…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer [Phase 2]
Phase 2 trial update evaluating anlotinib plus TQB2450 with nab-paclitaxel and cisplatin as first-line treatment for advanced biliary tract …